Luka Tandarić

3PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 14, 2026
Establishment of a humanized patient-derived xenograft mouse model of high-grade serous ovarian cancer for preclinical evaluation of combination immunotherapy.

Luka Tandaric, Line Bjørge, Martine Rott Lode

|Jan 31, 2025
Peripheral blood leukocyte signatures as biomarkers in relapsed ovarian cancer patients receiving combined anti-CD73/anti-PD-L1 immunotherapy in arm A of the NSGO-OV-UMB1/ENGOT-OV30 trial.

Luka Tandaric, Annika Auranen, Katrin Kleinmanns

|Apr 17, 2024
Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-Cell Lymphoma.

Leo Meriranta, Selma Sorri, Kanutte Huse

Pageof 1

Frequent Collaborators

1 joint publications

Leo Meriranta

1 joint publications

Selma Sorri

1 joint publications

Kanutte Huse

1 joint publications

Xiaonan Liu